Genus (GENSF) Stock Price, News & Analysis

Company Overview

Genus plc is a United Kingdom-based animal genetics company that develops and supplies breeding technologies and genetic products for the livestock industry. Its work is focused primarily on improving the productivity, health, efficiency and sustainability of cattle and pigs through selective breeding, genetic research and reproductive technologies.

The company operates through two principal businesses. ABS provides bovine genetics, breeding animals, reproductive services and related technology to dairy and beef producers. PIC focuses on porcine genetics, supplying breeding stock, genetic programs and technical support to pork producers. Genus also conducts research in areas including genomics, animal health and gene editing to support the development of improved livestock traits.

Genus serves agricultural customers in numerous markets across North America, Latin America, Europe, Asia and other international regions. The company traces its origins to the early 20th century and has developed from a UK-based breeding business into a global provider of animal genetics and related services. Its shares trade on the London Stock Exchange, while Genus plc is also quoted in the U.S. over-the-counter market under the symbol GENSF.

Key Stats

• Today's Range: $28.14 to $28.14
• 50-Day Range: $28.14 to $31.07
• 52-Week Range: $28.14 to $28.95
• Volume: N/A
• Average Volume: 150 shs
• Market Capitalization: N/A
• P/E Ratio: 59.12
• Dividend Yield: 0.59%
• Price Target: N/A
• Consensus Rating: Moderate Buy

Genus Stock Analysis - MarketRank™

Genus scored higher than 4% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Genus has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Genus has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Genus is 59.12, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.03.

Price to Earnings Ratio vs. Sector

The P/E ratio of Genus is 59.12, which means that it is trading at a more expensive P/E ratio than the Consumer Discretionary sector average P/E ratio of about 26.04.

Short Interest

• Score: 0.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Genus has a short interest ratio ("days to cover") of 806.78, which indicates bearish sentiment.

Change versus previous month

Short interest in Genus has recently increased by 0.67%, indicating that investor sentiment is decreasing.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Genus pays a meaningful dividend of 1.48%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Genus does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Genus is 34.87%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: N/A
• News Sentiment: N/A

Company Ownership

• Score: 0.4 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Genus insiders have not sold or bought any company stock.

Percentage Held by Institutions

29.70% of the stock of Genus is held by institutions.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Consumer Discretionary
• Industry: Diversified Consumer Services
• Sub-Industry: Specialized Consumer Services
• Current Symbol: OTCMKTS:GENSF
• CIK: N/A
• Web: www.genusplc.com
• Phone: 441256347100
• Fax: N/A
• Employees: 3,500
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 59.12
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A